Andrés Cervantes
- Oncology top 0.02%
- Pulmonary and Respiratory Medicine top 0.05%
- Surgery top 0.1%
- Molecular Biology top 1%
- Pathology and Forensic Medicine top 0.1%
- Co-authors
- Dirk ArnoldBernard NordlingerEmmanuel TiretEric Van CutsemDavid CunninghamWilliam AllumMarcel VerheijBengt Glimelius
- Topics
- Colorectal Cancer Treatments and Studies (165 papers)Gastric Cancer Management and Outcomes (87 papers)Cancer Treatment and Pharmacology (67 papers)
- Cited by
- OncologyHepatologyGastroenterology
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- SpainUnited StatesFrance
In The Last Decade
Andrés Cervantes
448 papers receiving 27.3k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Oncology 18.1k
- Pulmonary and Respiratory Medicine 9.4k
- Surgery 8.4k
- Molecular Biology 4.2k
- Pathology and Forensic Medicine 3.9k
Countries citing papers authored by Andrés Cervantes
This map shows the geographic impact of Andrés Cervantes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrés Cervantes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrés Cervantes more than expected).
Fields of papers citing papers by Andrés Cervantes
This network shows the impact of papers produced by Andrés Cervantes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrés Cervantes. The network helps show where Andrés Cervantes may publish in the future.
Co-authorship network of co-authors of Andrés Cervantes
This figure shows the co-authorship network connecting the top 25 collaborators of Andrés Cervantes. A scholar is included among the top collaborators of Andrés Cervantes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrés Cervantes. Andrés Cervantes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03breakdown → | 18 |
| 2 | 9 | |
| 3 | 8 | |
| 4 | 11 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 32 | |
| 8 | 9 | |
| 9 | 187 | |
| 10 | 29 | |
| 11 | 57 | |
| 12 | 58 | |
| 13 | 48 | |
| 14 | 119 | |
| 15 | 287 | |
| 16 | 46 | |
| 17 | 95 | |
| 18 | Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancerbreakdown → | 755 |
| 19 | ICON7: A PHASE III RANDOMISED GYNAECOLOGIC CANCER INTERGROUP TRIAL OF CONCURRENT BEVACIZUMAB AND CHEMOTHERAPY FOLLOWED BY MAINTENANCE BEVACIZUMAB, VERSUS CHEMOTHERAPY ALONE IN WOMEN WITH NEWLY DIAGNOSED EPITHELIAL OVARIAN (EOC), PRIMARY PERITONEAL (PPC) OR FALLOPIAN TUBE CANCER (FTC) | 34 |
| 20 | Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancerbreakdown → | 3040 |
About Andrés Cervantes
Andrés Cervantes is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 468 papers that have together received 27.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (165 papers), Gastric Cancer Management and Outcomes (87 papers) and Cancer Treatment and Pharmacology (67 papers). The work is most often cited by research in Oncology (18.1k citations), Hepatology (3.8k citations) and Gastroenterology (1.6k citations). Andrés Cervantes has collaborated with scholars based in Spain, United States and France. Frequent co-authors include Dirk Arnold, Bernard Nordlinger, Emmanuel Tiret, Eric Van Cutsem, David Cunningham, William Allum, Marcel Verheij, Bengt Glimelius, Rob Glynne‐Jones and Josep Tabernero. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.